Trials / Completed
CompletedNCT00650936
Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to prospectively evaluate the incidence of hemodynamic compromise and to obtain long-term survival data on patients with the AMPLATZER Septal Occluder
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AMPLATZER Septal Occluder | AMPLATZER Septal Occluder |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2008-04-02
- Last updated
- 2019-07-09
- Results posted
- 2019-06-25
Locations
51 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00650936. Inclusion in this directory is not an endorsement.